Results for “”

Entry Author Date Location
With FDA’s Eye on JAK Drugs, Concert Moves One Ahead For Hair Loss 09/03/19 Boston
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing 09/02/19 New York
Robocalls Crowd Out Real Business Calls. This Startup Has an Answer. 08/30/19 Seattle
Bio Roundup: Cholesterol Check, J&J’s Opioid Hit, AbbVie’s Flop & More 08/30/19 National
Celgene Adds Cell Therapies From Immatics With Bristol Sale in Sight 08/28/19 New York
Celgene to Sell Blockbuster Drug to Amgen for $13B to Close BMS Deal 08/26/19 New York
New PCSK9 Cholesterol Drug Faces Tough Foe. (Hint: Not Cholesterol.) 08/26/19 National
GSK’s Cancer Comeback Continues With Data for Multiple Myeloma Drug 08/23/19 National
Bio Roundup: Sarepta’s Stumble, Opioid Suits, Shkreli’s Legacy & More 08/23/19 National
Retrophin Sinks as Drug “Pharma Bro” Martin Shkreli Co-Invented Fails 08/22/19 San Diego
Ford’s Autonomic Connects EV Maker Ayro to Its Mobility Cloud 08/21/19 San Francisco
Elanco’s $7.6B Deal With Bayer Bolsters Pets, Farm Animals Footprint 08/20/19 Indiana
FDA Rejects Sarepta’s Second Duchenne Drug, Citing Safety Concerns 08/19/19 Boston
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs 08/16/19 New York
Bio Roundup: Zolgensma Fallout, Duchenne Redux, Ebola Boost & More 08/16/19 National
Will Porsche Fans Ever Live in a Driverless World? Porsche Says No. 08/16/19 San Francisco
Four New Drugs Are Around the Corner. Here’s What You Need to Know. 08/15/19 National
After Drought, Digital Health’s Summer of IPOs Brings Validation 08/14/19 National
Bio Roundup: Surprise News, a Gene Therapy Mess & a CAR-T Step 08/09/19 National
Bayer Buys Out BlueRock, Betting at Least $240M More on Cell Therapy Work 08/08/19 Boston
FDA: Despite “Manipulated” Data, $2M Gene Therapy Should Stay on Market 08/06/19 National
Another Delay for Intra-Cellular as FDA Extends Review of Psych Drug 08/05/19 New York
GlycoMimetics Sickle Cell Drug Flops as Others Creep Forward 08/05/19 New York
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More 08/02/19 National
Amicus Offers First Look At Gene Therapy Work With Batten’s Data 08/01/19 New York
White House Floats Canadian Import Plan But Excludes Many Costly Drugs 07/31/19 National
Mark Levin Named Xconomy’s 2019 Lifetime Achievement Award Winner in Boston 07/31/19 National
Upjohn & Mylan to Merge, Freeing Pfizer to Focus on Biopharma R&D 07/29/19 New York
Merck Data Are Another Step for Immunotherapy in Breast Cancer 07/29/19 New York
Duchenne Advocates Start Casimir, Aiming to Capture Missing Data 07/26/19 Boston
Page 2 of 86 « previous page · next page »